A 48-week, Double-blind, Randomized, Multi-center, Parallel-group Study Comparing Structural Changes in the Retina and Evolution of Visual Function After Immediate Versus Delayed Treatment With Fingolimod in Patients With Acute Demyelinating Optic Neuritis

Trial Profile

A 48-week, Double-blind, Randomized, Multi-center, Parallel-group Study Comparing Structural Changes in the Retina and Evolution of Visual Function After Immediate Versus Delayed Treatment With Fingolimod in Patients With Acute Demyelinating Optic Neuritis

Discontinued
Phase of Trial: Phase II

Latest Information Update: 16 Jun 2015

At a glance

  • Drugs Fingolimod (Primary)
  • Indications Optic neuritis
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 03 May 2015 Status changed from completed to discontinued as reported by ClinicalTrials.gov record.
    • 04 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 11 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top